Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water…
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE…
New data reinforces Ipsens commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14 abstracts will be presented across a range of neurological conditions including…
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
Weaviate named a Leader and Outperformer by GigaOm and Emerging Leader by Gartner; Market Momentum Accelerates as Nonrelational DBMS Segment Grows 22.7%
Amsterdam City, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Weaviate, the AI database…
CORRECTION Visionary Holdings Inc.
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under…
Renderforest 1.0 Strengthens Global Creative Production With Unified AI System
Renderforest expands its platform with its own proprietary AI model, enabling text,…
Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis
Not intended for US and UK audiences BI 765423 has been developed…
